Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer
Clinical trial NCT03104439 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03104439
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-10
- Primary completion
- 2027-01-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.